EP 1254235 A2 20021106 - DRUG METABOLIZING ENZYMES
Title (en)
DRUG METABOLIZING ENZYMES
Title (de)
ARZNEIMITTEL-METABOLISIERENDE ENZYME
Title (fr)
ENZYMES DE METABOLISATION DE MEDICAMENTS
Publication
Application
Priority
- US 0101174 W 20010112
- US 17613900 P 20000114
- US 17744300 P 20000121
- US 17857400 P 20000128
Abstract (en)
[origin: WO0151638A2] The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
IPC 1-7
C12N 15/52; C12N 9/00; C12N 15/63; C12N 5/10; A01K 67/027; C12P 21/00; C07K 16/40; C12Q 1/68; A61K 38/43; C12Q 1/00; G01N 33/573
IPC 8 full level
A01K 67/027 (2006.01); A61K 31/7088 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 3/00 (2006.01); A61P 3/10 (2006.01); A61P 5/00 (2006.01); A61P 7/02 (2006.01); A61P 7/06 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 15/00 (2006.01); A61P 17/00 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 21/04 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/04 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07K 16/40 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/00 (2006.01); C12N 9/02 (2006.01); C12N 9/10 (2006.01); C12N 9/14 (2006.01); C12N 15/09 (2006.01); C12Q 1/26 (2006.01); C12Q 1/34 (2006.01); C12Q 1/48 (2006.01); C12Q 1/68 (2006.01)
CPC (source: EP)
A61K 45/06 (2013.01); A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 3/00 (2017.12); A61P 3/10 (2017.12); A61P 5/00 (2017.12); A61P 7/02 (2017.12); A61P 7/06 (2017.12); A61P 9/04 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/12 (2017.12); A61P 15/00 (2017.12); A61P 17/00 (2017.12); A61P 19/02 (2017.12); A61P 19/10 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 25/08 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/04 (2017.12); A61P 37/06 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C12N 9/00 (2013.01); C12Y 101/01001 (2013.01); C12Y 205/01018 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0151638A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0151638 A2 20010719; WO 0151638 A3 20020321; AU 2790001 A 20010724; CA 2397340 A1 20010719; EP 1254235 A2 20021106; JP 2004500816 A 20040115
DOCDB simple family (application)
US 0101174 W 20010112; AU 2790001 A 20010112; CA 2397340 A 20010112; EP 01902057 A 20010112; JP 2001551212 A 20010112